These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 12640677)
1. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line. Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677 [TBL] [Abstract][Full Text] [Related]
2. Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro. Hayakawa N; Nozawa K; Ogawa A; Kato N; Yoshida K; Akamatsu Ki; Tsuchiya M; Nagasaka A; Yoshida S Biochemistry; 1999 Aug; 38(35):11501-7. PubMed ID: 10471302 [TBL] [Abstract][Full Text] [Related]
3. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells. Kim JH; Kim JH; Lee GE; Kim SW; Chung IK Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331 [TBL] [Abstract][Full Text] [Related]
4. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Zhang RG; Zhang RP; Wang XW; Xie H Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411 [TBL] [Abstract][Full Text] [Related]
5. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043 [TBL] [Abstract][Full Text] [Related]
6. A platinum(II) complex of liriodenine from traditional Chinese medicine (TCM): Cell cycle arrest, cell apoptosis induction and telomerase inhibition activity via G-quadruplex DNA stabilization. Li YL; Qin QP; Liu YC; Chen ZF; Liang H J Inorg Biochem; 2014 Aug; 137():12-21. PubMed ID: 24798373 [TBL] [Abstract][Full Text] [Related]
7. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733 [TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors. Herbert BS; Pongracz K; Shay JW; Gryaznov SM Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790 [TBL] [Abstract][Full Text] [Related]
9. TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules. Reed J; Gunaratnam M; Beltran M; Reszka AP; Vilar R; Neidle S Anal Biochem; 2008 Sep; 380(1):99-105. PubMed ID: 18534183 [TBL] [Abstract][Full Text] [Related]
10. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556 [TBL] [Abstract][Full Text] [Related]
11. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines. Parsch D; Brassat U; Brümmendorf TH; Fellenberg J Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350 [TBL] [Abstract][Full Text] [Related]
12. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802 [TBL] [Abstract][Full Text] [Related]
13. [Telomere and telomerase in human cancer]. Hiyama K; Hiyama E; Ishioka S; Yamakido M Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs]. Raymond E; Faivre S; Dieras V; Von Hoff D Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365 [TBL] [Abstract][Full Text] [Related]
16. Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme. Colangelo D; Ghiglia AL; Viano I; Cavigiolio G; Osella D Biometals; 2003 Dec; 16(4):553-60. PubMed ID: 12779240 [TBL] [Abstract][Full Text] [Related]
17. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents. Villa R; Folini M; Perego P; Supino R; Setti E; Daidone MG; Zunino F; Zaffaroni N Int J Oncol; 2000 May; 16(5):995-1002. PubMed ID: 10762636 [TBL] [Abstract][Full Text] [Related]
20. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA. Maji B; Bhattacharya S Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]